Shenzhen Neptunus Bioengineer (000078) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Shenzhen Neptunus Bioengineer Company Snapshot

Business Description:

Shenzhen Neptunus Bioengineer operates in the Drug stores and proprietary stores sector. Shenzhen Neptunus Bioengineering Co., Ltd is principally engaged in pharmaceutical manufacture and pharmaceutical commercial distribution businesses. The Company produces approximately 400 types of products, including chemical pharmaceuticals, biological pharmaceuticals, traditional Chinese medicines and healthcare products. The Company operates its businesses mainly in China's domestic markets with eastern China as its major market. As of December 31, 2010, the Company had five pharmaceutical bases, located in Shenzhen (Guangdong Province), Fuzhou (Fujian Province), Sanya (Hainan Province), and Hangzhou, China. In our complete report available for purchase the company is compared to: Chongqing Tong Jun Ge Company Limited, China National Medicines Corp., Ltd. and Zhejiang International Group Company Limited.

Shenzhen Neptunus Bioengineer

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 6.99
(Figures in Chinese Renmimbi)

1 Week	4.6%	13 Weeks	10.8%

4 Weeks	-13.2%	52 Weeks	-41.1%

Shenzhen Neptunus Bioengineer Key Data:

Ticker:	000078	Country:	CHINA

Exchanges:	SZN	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	3,999,052,000 (Year Ending Jan 2011).	Employees:	3,484

Currency:	Chinese Renmimbi	Market Cap:	4,561,047,591

Fiscal Yr Ends:	December	Shares Outstanding:	652,510,385

Share Type:	A Gu	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.